Molecular Fingerprint for Terminal Abdominal Aortic Aneurysm Disease

Abstract

Our study shows a specific molecular fingerprint for terminal AAA disease. These changes appear to converge at activation of HIF-1α signaling in mesenchymal cells. Aspects of this cascade might represent targets for rupture risk assessment.